NIO vs. EDIT

Last updated Jun 13, 2026

NIO (NIO Inc.) and EDIT (Editas Medicine, Inc.) are both stocks. NIO operates in Auto Manufacturers (Consumer Cyclical), while EDIT operates in Biotechnology (Healthcare). Over the past 5 years, NIO returned -35.22%/yr vs -41.79%/yr for EDIT. At a 0.35 correlation, their price movements are largely independent.

Performance

NIO vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NIO Inc. (NIO) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NIO achieves a 2.16% return, which is significantly lower than EDIT's 21.95% return.

NIO

• 1D: -0.38%
• 1M: -14.59%
• YTD: 2.16%
• 6M: 3.58%
• 1Y: 48.43%
• 3Y*: -16.32%
• 5Y*: -35.22%
• 10Y*: —

EDIT

• 1D: 2.46%
• 1M: -4.58%
• YTD: 21.95%
• 6M: -1.19%
• 1Y: 26.90%
• 3Y*: -39.82%
• 5Y*: -41.79%
• 10Y*: -22.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NIO vs. EDIT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
NIO NIO Inc.	2.16%	16.97%	-51.93%	-6.97%	-69.22%	-35.00%	1,112.44%	-36.89%	6.17%
EDIT Editas Medicine, Inc.	21.95%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	30.15%	-29.44%

Correlation

The correlation between NIO and EDIT is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.28
Correlation (5Y) Calculated over the trailing 5-year period	0.39
Correlation (All Time) Calculated using the full available price history since Sep 12, 2018	0.35

The correlation between NIO and EDIT shifts across timeframes, from 0.24 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap NIO : $12.93B EDIT : $244.70M
EPS NIO : -CN¥3.74 EDIT : -$1.21
PS Ratio NIO : 0.85 EDIT : 6.29
PB Ratio NIO : 20.18 EDIT : 55.51
Total Revenue (TTM) NIO : CN¥100.51B EDIT : $35.86M
Gross Profit (TTM) NIO : CN¥15.77B EDIT : $35.86M
EBITDA (TTM) NIO : -CN¥7.54B EDIT : -$76.66M

Return for Risk

NIO vs. EDIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NIO

NIO Risk / Return Rank: 64
NIO Sharpe Ratio Rank: 66
NIO Sortino Ratio Rank: 66
NIO Omega Ratio Rank: 61
NIO Calmar Ratio Rank: 64
NIO Martin Ratio Rank: 60

EDIT

EDIT Risk / Return Rank: 51
EDIT Sharpe Ratio Rank: 48
EDIT Sortino Ratio Rank: 56
EDIT Omega Ratio Rank: 53
EDIT Calmar Ratio Rank: 49
EDIT Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NIO vs. EDIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NIO Inc. (NIO) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NIO	EDIT	Difference
Sharpe ratio: Return per unit of total volatility	0.70	0.16	+0.55
Sortino ratio: Return per unit of downside risk	1.43	0.98	+0.45
Omega ratio: Gain probability vs. loss probability	1.16	1.11	+0.05
Calmar ratio: Return relative to maximum drawdown	1.01	0.25	+0.76
Martin ratio: Return relative to average drawdown	1.78	0.43	+1.35

NIO vs. EDIT - Sharpe Ratio Comparison

The current NIO Sharpe Ratio is 0.70, which is higher than the EDIT Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of NIO and EDIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NIO vs. EDIT - Drawdown Comparison

The maximum NIO drawdown since its inception was -95.00%, roughly equal to the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for NIO and EDIT.

Drawdown Indicators

	NIO	EDIT	Difference
Max Drawdown Largest peak-to-trough decline	-95.00%	-98.92%	+3.92%
Max Drawdown (1Y) Largest decline over 1 year	-43.73%	-59.88%	+16.15%
Max Drawdown (3Y) Largest decline over 3 years	-79.69%	-91.18%	+11.49%
Max Drawdown (5Y) Largest decline over 5 years	-94.10%	-98.66%	+4.56%
Max Drawdown (10Y) Largest decline over 10 years	—	-98.92%	—
Current Drawdown Current decline from peak	-91.71%	-97.24%	+5.53%
Average Drawdown Average peak-to-trough decline	-67.90%	-62.63%	-5.27%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.74%	34.03%	-9.29%

Volatility

NIO vs. EDIT - Volatility Comparison

The current volatility for NIO Inc. (NIO) is 17.58%, while Editas Medicine, Inc. (EDIT) has a volatility of 32.34%. This indicates that NIO experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NIO	EDIT	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.58%	32.34%	-14.76%
Volatility (6M) Calculated over the trailing 6-month period	41.08%	61.63%	-20.55%
Volatility (1Y) Calculated over the trailing 1-year period	62.74%	94.75%	-32.01%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	71.62%	94.12%	-22.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	86.66%	83.80%	+2.86%

Dividends

NIO vs. EDIT - Dividend Comparison

Neither NIO nor EDIT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both NIO and EDIT in my portfolio?

NIO and EDIT have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NIO or EDIT?

EDIT has higher volatility (32.34%) compared to NIO (17.58%). In terms of maximum drawdown, NIO dropped -95.00% vs EDIT's -98.92%.

Which has better risk-adjusted returns?

NIO currently has the higher Sharpe Ratio (0.70 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.